It is established that GPCRs function through binding to Gα subunit (e.g., Gαs, Gαi/o, Gα12/13, and Gαq/11) to activate or inactivate downstream signals (phospholipase C, AC, phosphoinositide 3-kinases) to promote or inhibit tumor progression. Here, ASAH1 is linked to neoplasm.